We describe a patient with concomitant B-cell chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). CLL- and MM-cell were separated by preparative flourescence-activated cell sorting (FACS). DNA sequence analy...
详细信息
We describe a patient with concomitant B-cell chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). CLL- and MM-cell were separated by preparative flourescence-activated cell sorting (FACS). DNA sequence analysis of the complementarity-determinining region III (CDR III) of the immunoglobulin heavy chain genes showed identical gene rearrangements in the CLL- and the MM-cell population. Our findings prove a common clonal tumor origin of both B-cell diseases in this patient.
This report is a retrospective analysis of 27 patients who received Tacrolimus because of intol- erance or for refractoriness to Cyclosporin A (CyA) as prophylaxis against acute and chronic GvHD at a single institut...
详细信息
This report is a retrospective analysis of 27 patients who received Tacrolimus because of intol- erance or for refractoriness to Cyclosporin A (CyA) as prophylaxis against acute and chronic GvHD at a single institution. 9 patients were treated with Tacrolimus as acute GvHD developed despite optimal concentrations of CyA and 8 developed chronic GvHD despite continuation of CyA. 10 patients developed World Health Organisation Score (WHO) grade 2–3 toxicity to CyA. Overall 21 of 27 patients responded to Tacrolimus. Patients who underwent reduced conditioning responded as well as those patients who un- derwent conventional conditioning regimens. Tacrolimus is well tolerated and e?ective and might be an alternative primary agent for prevention of GvHD. Its role in reduced conditioning regimens needs to be further explored.
暂无评论